You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

angioimmunoblastic

Showing 26 - 50 of 248
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T Lymphoblastic Leukemia/Lymphoma, Extramedullary NK-T-cell Lymphoma, Nasal Type, Peripheral T-cell Lymphoma, Nonspecific Trial

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +6 more
  • T cell injection targeting CD7 chimeric antigen receptor
  • Zhengzhou, Henan, China
    First Affiliated Hospital of Zhengzhou University
Jan 4, 2021

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

Active, not recruiting
  • T-Cell Lymphoma
  • +4 more
  • LB1901
  • Rochester, Minnesota
  • +3 more
Feb 15, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma, ALK-negative Anaplastic Large Cell

Unknown status
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • +5 more
  • CEOP/IVE/GDP chemotherapy regimen
  • CEOP chemotherapy regimen for 6 cycles
  • Fuzhou, Fujian, China
  • +3 more
Mar 7, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

Not yet recruiting
  • T-Cell Neoplasm
  • Lymphoproliferative Disorders
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Oct 6, 2022

Adult T-Cell Lymphoma/Leukaemia, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in Wuhan (Anti-CD30

Recruiting
  • Adult T-Cell Lymphoma/Leukaemia
  • +5 more
  • Anti-CD30 CAR T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 5, 2019

Risk Stratification of Nodal PTCL

Completed
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • +2 more
    • Jeonju, Korea, Republic of
      Chonbuk Nationla University Hospital
    Aug 5, 2019

    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

    Terminated
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +116 more
    • brentuximab vedotin
    • +2 more
    • Chicago, Illinois
    • +2 more
    Aug 30, 2021

    A Study of Chinese Adults With Lymphoma

    Recruiting
    • Lymphoma
      • Beijing, Beijing, China
      • +18 more
      Nov 3, 2022

      Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

      Recruiting
      • Peripheral T-cell Lymphoma
      • PD-1 antibody+ HDAC inhibitor
      • Shanghai, Shanghai, China
        Dongmei Ji
      Dec 3, 2021

      NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

      Recruiting
      • NK-Cell Lymphoma
      • +2 more
      • San Francisco, California
      • +1 more
      Sep 1, 2021

      Peripheral T-cell Lymphomas (PTCL) Trial in Taiwan (Lenalidomide and Gemcitabine (Dose level 11), Lenalidomide and Gemcitabine

      Not yet recruiting
      • Peripheral T-cell Lymphomas (PTCL)
      • Lenalidomide and Gemcitabine (Dose level 11)
      • +3 more
      • Kaohsiung, Taiwan
      • +3 more
      Nov 1, 2021

      Lymphoma Trial in Berne (Brentuximab Vedotin, BeEAM Regimen)

      Recruiting
      • Lymphoma
      • Brentuximab Vedotin
      • BeEAM Regimen
      • Berne, Switzerland
        Department for Medical Oncology University Hospital/Inselspital
      Feb 4, 2022

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

      Recruiting
      • Brain and Central Nervous System Tumors
      • +8 more
      • 3'-deoxy-3'-[18F]fluorothymidine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Mar 30, 2022

      A Study of People With CD30 Positive Lymphoma in China

      Not yet recruiting
      • Lymphoma
        • (no location specified)
        Aug 17, 2022

        Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)

        Completed
        • Relapsed or Refractory Peripheral T-Cell Lymphoma
        • Palo Alto, California
        • +12 more
        Apr 26, 2021

        Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

        Completed
        • Brain and Central Nervous System Tumors
        • +10 more
        • Chicago, Illinois
          Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
        Sep 3, 2021

        Tissue, Blood, and Body Fluid Sample Collection From Hematologic

        Recruiting
        • Chronic Myeloproliferative Disorders
        • +7 more
        • biologic sample preservation procedure
        • cytology specimen collection procedure
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Oct 14, 2021

        T-Cell Lymphoma Trial (Brentuximab vedotin, Pembrolizumab)

        Not yet recruiting
        • T-Cell Lymphoma
        • (no location specified)
        Jul 22, 2022

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +35 more
        • Duarte, California
        • +4 more
        Dec 24, 2019

        Peripheral T Cell Lymphoma Trial in France (Chemotherapy + follow up, Chemotherapy + ASCT + follow up)

        Recruiting
        • Peripheral T Cell Lymphoma
        • Chemotherapy + follow up
        • Chemotherapy + ASCT + follow up
        • Amiens, France
        • +47 more
        Aug 2, 2022

        Collecting and Storing Blood Samples From Patients With Cancer

        Withdrawn
        • Brain and Central Nervous System Tumors
        • +10 more
          • (no location specified)
          Sep 20, 2021